Cannabis and Sleep Apnea
What the evidence actually says about using cannabis or cannabinoids to treat obstructive sleep apnea — and why guidelines say not to.
Cannabis is not a treatment for sleep apnea. One synthetic cannabinoid (dronabinol) showed a modest reduction in apnea events in small trials, which got people excited — but the American Academy of Sleep Medicine specifically recommends against using medical cannabis or synthetic cannabinoids for OSA, because the evidence is weak, the side effects are real, and CPAP and weight loss actually work. If you have sleep apnea and you're self-medicating with weed at bedtime, you may be making it worse, not better.
This is not medical advice
This article summarizes published research and clinical guidelines. It is not a substitute for evaluation by a sleep physician. Untreated obstructive sleep apnea raises your risk of heart attack, stroke, and fatal car crashes. If you suspect you have sleep apnea — loud snoring, witnessed pauses in breathing, daytime sleepiness — get a sleep study. Do not use this article to delay diagnosis or replace CPAP.
Plain-language summary
Obstructive sleep apnea (OSA) is a condition where the muscles of your upper airway relax too much during sleep, blocking airflow. You stop breathing for seconds at a time, dozens or hundreds of times a night, and your oxygen drops. The standard treatment is CPAP (continuous positive airway pressure), which physically holds the airway open with pressurized air [1].
Researchers have looked at cannabinoids for OSA because THC affects serotonin signaling, which in turn affects the muscles of the upper airway. A small number of trials with dronabinol — a synthetic THC pill, FDA-approved for nausea and appetite, not for sleep apnea — showed modest reductions in the apnea-hypopnea index (AHI) [2][3]. That's the entire evidence base.
No trial has shown that smoked or vaped cannabis improves sleep apnea. The American Academy of Sleep Medicine reviewed the evidence in 2018 and explicitly recommended against using medical cannabis or synthetic cannabis extracts to treat OSA, citing weak evidence, unknown long-term effects, and variable cannabis composition [4].
What probably works (for OSA specifically)
Nothing in the cannabis category meets a 'probably works' bar for sleep apnea. No data
For context, here is what does work and is well-supported:
- CPAP reduces AHI to near-normal in most patients and improves daytime sleepiness, blood pressure, and quality of life Strong evidence[1].
- Weight loss of 10% or more substantially reduces AHI in patients with obesity-related OSA Strong evidence[5].
- Mandibular advancement devices work for mild-to-moderate OSA Strong evidence[1].
- Positional therapy for patients whose apneas occur mainly on their back Strong evidence.
If you are reading this hoping cannabis can replace one of the above: it cannot, based on current evidence.
What might work (weak evidence)
Dronabinol (synthetic THC). Two small proof-of-concept trials by Carley and colleagues at the University of Illinois at Chicago tested dronabinol in adults with moderate-to-severe OSA. In the phase II PACE trial (n=73), dronabinol 2.5–10 mg taken before bed reduced AHI by roughly 33% compared to placebo over six weeks, and patients reported improved subjective sleepiness Weak / limited[2][3].
Why 'weak' and not 'strong':
- Only ~73 subjects total across the published trials.
- Short duration (6 weeks). OSA is a lifelong condition.
- The AHI reduction, while statistically significant, did not bring most patients to a non-apneic range — they still had clinically significant OSA.
- No replication by an independent group.
- No data on cardiovascular outcomes, which is what we actually care about in OSA.
The AASM specifically reviewed these trials and still recommended against clinical use, calling the evidence insufficient [4].
What doesn't work or has no evidence
Smoked or vaped cannabis flower. There are zero controlled trials showing it improves AHI, oxygen saturation, or daytime sleepiness in OSA patients. No data
CBD. No trials have tested CBD as a treatment for sleep apnea. No data CBD's effects on sleep architecture in healthy people are mixed and dose-dependent [6].
Cannabis for snoring. Folklore. No evidence. Alcohol and cannabis are both upper-airway muscle relaxants, and there is a reasonable mechanistic concern that inhaled cannabis at bedtime could worsen upper airway collapsibility, particularly in people who already have OSA. Anecdote
'Indica' strains for sleep apnea. The indica/sativa distinction does not reliably predict effects [7], and even if it did, sedation is not the same thing as treating apnea. A person who is more deeply sedated but still not breathing has not been helped — they may simply be less arousable, which in severe OSA is dangerous.
What we don't know
- Whether dronabinol's effect persists beyond 6 weeks, or whether tolerance develops.
- Whether any cannabinoid reduces the cardiovascular complications of OSA (heart attack, stroke, hypertension).
- Whether cannabis worsens, improves, or doesn't affect central sleep apnea (where the brain fails to signal breathing, as opposed to airway obstruction). There is theoretical concern that opioid-like respiratory depression mechanisms could be relevant, but no good data.
- Whether chronic cannabis use changes sleep architecture in ways that interact with OSA (REM rebound on withdrawal, for example, could increase apneas since most obstructive events occur in REM).
- What dose, formulation, or cannabinoid ratio — if any — would be optimal.
Comparison with standard treatments
| Treatment | Typical AHI reduction | Evidence | Notes | |---|---|---|---| | CPAP | 80–95% (to near-normal) | Strong [1] | First-line; adherence is the main challenge | | Mandibular advancement device | 40–60% | Strong [1] | Best for mild–moderate OSA | | Weight loss (≥10%) | 25–50% | Strong [5] | Durable if weight is kept off | | Hypoglossal nerve stimulation (Inspire) | ~50–70% | Moderate-strong | For CPAP-intolerant moderate–severe OSA | | Dronabinol | ~33% (6-week data) | Weak [2][3] | Not approved for OSA; AASM recommends against | | Smoked/vaped cannabis | Unknown | None | May worsen airway collapsibility |
Dronabinol is the worst-performing intervention on this list and also the least studied. There is no clinical scenario in which it is the right first choice.
Risks of using cannabis if you have sleep apnea
- Upper airway muscle relaxation. THC, like alcohol and benzodiazepines, can relax the muscles that keep your airway open. In people with OSA, this is the wrong direction. Weak / limited
- Reduced arousal from apneic events. Sedatives blunt the brain's ability to wake you up when oxygen drops. Cannabis is sedating. This is a theoretical but plausible concern. Weak / limited
- Smoking-related airway inflammation. Combusted cannabis irritates the upper and lower airways Strong evidence[8], which is not helpful in a disease defined by airway dysfunction.
- Delayed diagnosis. Using cannabis to feel like you slept better can mask symptoms (daytime sleepiness, unrefreshing sleep) and delay a sleep study.
- CPAP adherence. Some patients report using cannabis instead of CPAP. This is the worst possible substitution: a treatment with strong evidence replaced by one with none.
If you have diagnosed OSA and you use cannabis, talk to your sleep physician honestly about it. Don't stop CPAP.
Sources
- Peer-reviewed Patil SP, Ayappa IA, Caples SM, et al. Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. 2019;15(2):335-343.
- Peer-reviewed Carley DW, Prasad B, Reid KJ, et al. Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea. Sleep. 2018;41(1):zsx184.
- Peer-reviewed Prasad B, Radulovacki MG, Carley DW. Proof of concept trial of dronabinol in obstructive sleep apnea. Frontiers in Psychiatry. 2013;4:1.
- Peer-reviewed Ramar K, Rosen IM, Kirsch DB, et al. Medical Cannabis and the Treatment of Obstructive Sleep Apnea: An American Academy of Sleep Medicine Position Statement. Journal of Clinical Sleep Medicine. 2018;14(4):679-681.
- Peer-reviewed Foster GD, Borradaile KE, Sanders MH, et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes (Sleep AHEAD). Archives of Internal Medicine. 2009;169(17):1619-1626.
- Peer-reviewed Babson KA, Sottile J, Morabito D. Cannabis, Cannabinoids, and Sleep: a Review of the Literature. Current Psychiatry Reports. 2017;19(4):23.
- Peer-reviewed Smith CJ, Vergara D, Keegan B, Jikomes N. The phytochemical diversity of commercial Cannabis in the United States. PLoS One. 2022;17(5):e0267498.
- Peer-reviewed Tashkin DP. Effects of marijuana smoking on the lung. Annals of the American Thoracic Society. 2013;10(3):239-247.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.